TJL Pharmaceutical's Kabul manufacturing facility has successfully completed its annual current Good Manufacturing Practice (cGMP) audit with zero critical observations — a result that reflects years of disciplined investment in quality systems, staff training and facility upgrades.
What the Audit Covered
The audit examined cleanroom operation and environmental monitoring, water system validation, sterilization cycle records, batch documentation, laboratory data integrity, deviation and CAPA management, and staff training records across all production lines.
Quality as a System
"Quality is not a step in our process — it is the system itself," said the TJL quality leadership team. "This result belongs to every operator, analyst and engineer who treats each batch as if it were destined for their own family."
The outcome strengthens TJL's registration dossiers across current and new markets, supporting the company's expanding international distribution footprint.
Interested in this product or partnership?
Our export team responds to all enquiries within one business day.
